Clinical Trial of Clarithromycin, Lenalidomide and Dexamethasone in the Treatment of the First Relapsed Multiple Myeloma

Clinical trial NCT04063189 · UNKNOWN

Trial details

NCT number: NCT04063189
Sponsor: The First Hospital of Jilin University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma in Relapse

Start date: 2017-03-21
Primary completion: 2020-02-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.